Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Enanta, among Boston's few profitable biotechs, earns another $30M
Enanta, among Boston's few profitable biotechs, earns another $30M
Enanta, among Boston's few profitable biotechs, earns another $30M
Submitted by
admin
on September 28, 2015 - 8:41am
Source:
Bizjournals.com
News Tags:
Enanta
AbbVie
hepatitis C
Viekirax
Headline:
Enanta, among Boston's few profitable biotechs, earns another $30M
Do Not Allow Advertisers to Use My Personal information
